As several TLR7 or TLR7/8 agonists are under clinical development for the treatment of various diseases including respiratory allergies (Hennessy et al, 2010; Kanzler et al, 2007), their efficacy in clinical trials of allergic asthma exacerbations are eagerly awaited. This evidence concerns the gene TLR7 and allergic respiratory disease.